Ventyx Biosciences Inc (NASDAQ: VTYX) kicked off on Friday, down -6.98% from the previous trading day, before settling in for the closing price of $9.03. Over the past 52 weeks, VTYX has traded in a range of $0.78-$10.55.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -87.13%. While this was happening, its average annual earnings per share was recorded 26.52%. With a float of $63.98 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 10.34%, while institutional ownership is 61.91%. The most recent insider transaction that took place on Dec 18 ’25, was worth 365,461. In this transaction CEO AND PRESIDENT of this company sold 47,345 shares at a rate of $7.72, taking the stock ownership to the 2,372,863 shares. Before that another transaction happened on Dec 18 ’25, when Company’s CHIEF SCIENTIFIC OFFICER sold 12,675 for $7.72, making the entire transaction worth $97,840. This insider now owns 489,481 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.41 earnings per share (EPS), higher than consensus estimate (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.89% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Take a look at Ventyx Biosciences Inc’s (VTYX) current performance indicators. Last quarter, stock had a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
As of the previous 9 days, the stock’s Stochastic %D was 61.29%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 74.10%, which indicates a significant increase from 41.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.57 in the past 14 days, which was higher than the 0.48 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.61, while its 200-day Moving Average is $3.84. Now, the first resistance to watch is $8.87. This is followed by the second major resistance level at $9.34. The third major resistance level sits at $9.66. If the price goes on to break the first support level at $8.08, it is likely to go to the next support level at $7.76. The third support level lies at $7.29 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
The company with the Market Capitalisation of 599.41 million has total of 71,359K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -135,120 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -22,830 K.
